Aim: Lamotrigine (LTG) is a widely used anti-epileptic drug that is administered to avoid seizures and to maintain seizure-free status. However, several factors reportedly cause individual differences of plasma LTG levels, and the therapeutic target range of LTG varies between individuals. Thus, to optimize effective doses of LTG, we developed a rapid and simple method for determining plasma LTG concentrations.
drugs that affect UGT activities, such as valproic acid and phenytoin, likely affect the metabolism of LTG. 5, 7, 8 Renal replacement therapy also influenced plasma concentrations of LTG, 9, 10 because LTG was likely to be removed during hemodialysis. 10 Moreover, switching from branded drugs to generic formulations or from one generic formulation to another reportedly provoked breakthrough seizures and other negative consequences, probably due to changes in intestinal absorption. [11] [12] [13] Therefore, to control individual plasma LTG levels through the selection of appropriate dosing regimens, we developed a rapid, simple, and available method to detect plasma concentrations of LTG over a wide range by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
| ME TH ODS

| Chemicals and reagents
Lamotrigine (purity > 98.0%) was purchased from Sigma-Aldrich Co. 
| Liquid chromatography
The LC system comprised a Shimadzu Nexera X2 HPLC (Shimadzu Corporation, Kyoto Japan) equipped with a binary pump (LC-30AD)
and an autosampler (SIL-30AC). Chromatography was performed on a Cadenza CD-C18 column (100 × 2 mm, 3 μm, Imtakt Corporation, Kyoto, Japan) maintained at 40°C. The mobile phase comprised 0.1% formic acid in water and acetonitrile (2/1, v/v) and was eluted at a flow rate of 0.2 mL/min. The injection volume was 5 μL.
| Mass spectrometry
Quantification was achieved by MS/MS detection in positive ion mode for LTG and papaverine that was used as internal standard (IS) using a Shimadzu LCMS-8040 triple quadrupole mass spectrometer equipped with electrospray source for ion production. The MS parameters were optimized with auto-optimized software by infusing standard solutions of LTG and IS (100 ng/mL). Optimal parameters were as follows: nebu- 
| Preparation of working solutions
Lamotrigine and IS were diluted with acetonitrile/water (50/50, v/v) to 100 μg/mL and 4 μg/mL, respectively, and then were stored at −30°C until use as stock solutions. The working solutions of both LTG and IS were prepared from their stock solutions with acetonitrile/water (50/50, v/v) immediately before use. Final concentrations of LTG calibration curves were 0.2-5.0 μg/mL. Regarding IS, the final concentration was 0.8 μg/mL.
| Preparation of quality control samples
Quality control (QC) samples were prepared for method validation, and final concentrations of low-quality control (LQC), medium-quality control (MQC), and high-quality control (HQC) samples were 0.2, 2.0, and 5.0 μg/mL, respectively.
| The extraction of LTG
Lamotrigine extraction was performed using the solid-phase extraction (SPE) method. Oasis hydrophilic lipophilic balance (HLB) cartridges (1 cc, 10 mg; Waters) were conditioned using 1.0 mL of methanol followed by 1.0 mL of distilled water. In brief, the extrac- 
| Recovery
Recovery rates of LTG and IS were determined after preparing samples using blank plasma. LTG and IS were then added to eluted samples and were adjusted to theoretical concentrations. The recovery was calculated by comparing peak areas obtained from extracted spiked QC samples with those of the postextracted spiked samples.
| Carryover peak
Carryover peak was assessed by checking peaks in LTG and IS peak regions of blank sample (no LTG or IS) injections after HQC (5.0 μg/mL) sample injection. This procedure was repeated three times.
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| Method validation
The method was fully validated according to the Food Drug Administration guidance for biological method validation. 
| Specificity and selectivity
Specificity and selectivity of the method were evaluated using human plasma at five different lots by investigating potential interferences at peak regions of LTG and IS.
| Matrix effect
Matrix effects of human plasma constituents were evaluated from the ratio of ionization responses of LTG and IS between human blank plasma samples and diluting solvent. QC samples were prepared with human plasma in four different lots and matrix effects on LTG were determined in LQC, MQC, and HQC samples. Matrix effects on IS were determined at a single concentration of 0.8 μg/mL.
| Linearity
A six-point calibration curve was constructed by plotting LTG/IS peak area ratios against nominal concentrations of calibration standards in human plasma. Linearity was evaluated using linear regression analyses with the least squares method.
| Intra-and inter-day accuracy and precision
Intra-assay precision and accuracy were evaluated by repeating analyses of QC plasma samples in five independent runs at three LTG concentrations (LQC, MQC, and HQC) in one day. Inter-assay precision and accuracy were evaluated by analyzing three QC samples on five different days. Accuracy was considered acceptable when the relative error (RE) was within ±15%, and precision was considered acceptable at a relative standard deviation (RSD) of less than 15% except at lower limit of quantification should not deviate by more than 20%.
| Stability
The stability of LTG was determined in LQC, MQC, and HQC samples.
The stability of LTG in injection solvent was evaluated by injecting prepared samples after storage at 15°C in the autosampler for 6 hours from the first cycle injection. Peak area ratios of LTG and IS at the initial cycle were used as standards to determine 6-hour stability at corresponding concentrations. The stability of LTG in human plasma was evaluated at room temperature for 5 hours. The stability of LTG in human plasma following three freeze-thaw cycles was assessed by analyzing QC samples after the third round of thawing. In these experiments, samples were thawed at room temperature for approximately 1 hour and were then frozen and stored at −30°C until the next thaw.
Short-term stability of LTG in human plasma was assessed by analyzing QC samples after storage at 4°C for 12 hours. Long-term stability of LTG in human plasma was assessed by analyzing QC samples after storage at −30°C for 3 months. The stability of LTG in diluting solvent was assessed by analyzing LTG working solution after storage at room temperature for 6 hours at LTG concentrations of LQC, MQC, and HQC. Peak area ratios of LTG and IS from these samples were then compared with standard samples, which were analyzed soon after diluting and spiking at corresponding concentrations. In all experiments, the criteria for acceptability of accuracy and precision were as described for intra-and inter-day accuracy and precision experiments.
3 | RESULTS
| Mass spectroscopy conditions
To optimize electrospray ionization conditions for LTG and IS, we determined Q1 pre bias, collision energy, and Q3 pre bias in positive ion detection mode. Following ionization and collision, the LTG Figure 2A ). The mass spectra showed the main product ion was the fragment at m/z 43.0, followed by the product ion at m/z 210.8. The product ions at m/z 43.0 15 and 210.8 [16] [17] [18] were also used to measure LTG reported in previous studies. We then selected the product ion at m/z 210.8 for the measurement LTG due to peak forms and quantitative stability. The mass spectra for IS showed that the fragment at m/z 324.3 was the main product ion ( Figure 2B ) and the product ion showed quantitative stability (data not shown). Therefore, we selected product ion of the m/z 324.3 for the measurement of IS.
| Sample preparation and liquid chromatography conditions
In the present experiments, we performed experiments using various ratios of organic (acetonitrile and methanol) and aqueous solvents with buffering effects at various concentrations with and without formic acid. We also compared normal and reverse phase columns. Optimal peaks and electrospray responses for LTG and IS were achieved with 0.1% formic acid in water/acetonitrile (2/1, v/v) using a Cadenza CD-C18 column (100 × 2 mm, 3 μm). Under these conditions, Rts for LTG and IS were 1.6 and 2.0 minutes, respectively, and the total run time was 3.5 minutes. In experiments with various injection volumes of LTG, the linear relationship between LTG contents and IS peaks deteriorated following injections of greater than 1 ng LTG (data not shown). Thus, to ensure that injections contained less than 1 ng of LTG, we diluted 50 μL aliquots of plasma with 500 μL aliquots of elution buffer, diluted 100 μL aliquots of eluted solvent with 300 μL of 0.1% formic acid, and set the injection volume to 5 μL.
Samples were prepared using the SPE method. The Oasis HLB cartridges are reportedly suitable for extraction of various analytes due to the presence of both hydrophilic and hydrophobic groups.
We slightly modified the SPE method which was provided by the manufacturer. After sample loading, cartridges were washed twice in 1 mL of distilled water, which reduced protein contents of eluents more effectively than single wash. Moreover, as suggested by the column manufacturer, we also eluted using acetonitrile/methanol (9/ 1, v/v), which prevented ionization of the analyte. This solvent also improved the shape of the LTG form and decreased the height of a shoulder peak of LTG. Based on these investigation, we finally obtained chromatographic peaks of LTG and IS ( Figure 3A ,B).
| Selection of IS
Papaverine was used as IS because it has demonstrated the good recovery of 96.3% without interfering the detection of LTG with a Rt of 2.0 minutes ( Figure 3A ,B)
| Recovery
Recovery rates of LTG were determined in three independent runs of LQC, MQC, and HQC and were good at all concentrations (93.8%-98.6%) (data not shown).
F I G U R E 2 Mass spectra of LTG and IS.
A, Mass spectra of LTG at Rt of 1.6 min; B, Mass spectra of LTG at Rt of 2.0 min ITABASHI ET AL.
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| Specificity, selectivity, and matrix effects
Regarding the matrix effect, the precision among different lots of human plasma was 11.86% (LQC), 4.05% (MQC), and 3.20% (HQC) and that of IS was 2.05% (0.8 μg/mL) (data not shown). No significant interfering peaks were observed in LTG and IS peak regions ( Figure 3C ).
| Linearity
The present plasma calibration curve was generated with six concentrations between 0.2 and 5.0 μg/mL and showed reproducibility across the range, with an average correlation coefficient (r 2 ; n = 2) of >0.99 ( Figure 3D ). The lower limit of quantitation was the same as the lowest concentration (0.2 μg/mL), and calculated LTG concentrations were within ±15% of standard concentrations at all calibration points. Finally, the area ratio of the largest noise peak in blank plasma over the LTG peak (0.2 μg/mL) was more than five times, indicating good detection with little interference.
| Precision and accuracy
Intra-and inter-day accuracy and precision in LTG plasma samples met the criteria in all cases, and RSD of each sample was between 1.1 and 6.8%, showing good reproducibility (Table 1) . Table 2 showed the stability of LTG. LTG was stable for 6 hours at room temperature in diluting solvent. Moreover, LTG in human plasma was stable for 5 hours at room temperature, for 12 hours at 4°C, for 3 months at −30°C, and following three freeze-thaw cycles.
| Stability
Moreover, stability of LTG in autosampler met the criteria.
| Carryover peak
No significant interfering peaks were detected from blank samples after injections of HQC samples (data not shown).
| DISCUSSION
In the present study, we established and validated the measurement method of LTG in plasma. Regarding the calibration curve range, we selected the range of 0.2-5.0 μg/mL since drug information of LTG showed that average trough levels of LTG are 2.81-4.12 μg/mL and the minimum trough level is also 0.32 μg/mL. 19 Drug information of LTG also showed the maximum trough level is 13.3 μg/mL. 19 Additionally, the guideline of the Japanese Journal of Therapeutic Drug
Monitoring has recommended 2.5-15 μg/mL in plasma for therapeutic range of LTG. 20 So, our range is slightly low. However, if the concentration of LTG is higher than 5.0 μg/mL, further dilution would be applicable. The noncompliance and the removal of LTG by hemodialysis might cause epileptic seizure due to the decrement of LTG below therapeutic range. In that cases, precise valued of the concentration of LTG would be needed to adjust it dosage.
Our method detected with Rts for LTG and IS of 1.6 and 2.0 minutes, respectively, and a total run time of 3.5 minutes. These parameters led to faster determinations than shown in previous reports. 15, 17, 21 Lamotrigine has the structure of an aromatic amine and interacts with chromatographic solid phases. 24 Although LTG could be separated using a normal-phase Unison UK-silica column with a mobile phase containing 0.05% formic acid in methanol/water (50/50, v/v), reverse-phase separation using a C18 column with acetonitrile instead of methanol further improved LTG detection, as shown in numerous previous reports. 17, 19, 25 We selected papaverine as IS since easily purchasable papaverine is rarely coadministered with LTG and it had a good recovery in the present method, although previous studies used lamotrigine-
as an IS for LTG determinations. 17, 18, 26 Moreover, intra-and interday precision for IS was within approximately 5% (data not shown).
Thus, these results indicate that papaverine is suitable as an IS for the measurements of LTG.
Regarding sample preparation, several studies have demonstrated methods for extracting LTG from plasma using protein precipitation with organic solvents such as methanol and acetonitrile. 15, 18, 22, 26 However, other studies were used SPE method. 16, 25, 27, 28 In general, human plasma constituents frequently inhibit ionization of analytes in LC-MS/MS quantifications. [29] [30] [31] Moreover, it has been reported that protein precipitation is unable to sufficiently remove phospholipids which are one of major factor to inhibit the ionization. 31 Thus, we employed the SPE method using the Oasis HLB cartridge and obtained chromatographic peaks of LTG and IS. The present method did not require drying under nitrogen, providing greater simplicity of methods for preparing samples than those reported previously 25, 27, 28 and shortened sample preparation times.
Validation experiments showed that LTG is stable in human plasma and that our measurement system is highly quantitative in the range of 0.2-5.0 μg/mL. The experiments for intra-and inter-day validation showed good reproducibility with RSD values at around 5%. Moreover, LTG under each storage conditions also met the criteria.
In conclusion, we developed a rapid and simple method for determining plasma LTG concentrations and show good validation for a relatively wide range (0.2-5.0 μg/mL) of LTG concentrations.
Using the present method sample preparation takes approximately 30 minutes and plasma LTG concentrations are detected in a 3.5-minute run time. Thus, the present method could be used clinically for rapid estimates of plasma LTG concentrations within 1 hour of sample collection. This method could be used to inform LTG dose adjustments for individual patients.
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